Cargando…
A Case of Hypophosphatemia with Increased Urinary Excretion of Phosphorus Associated with Ibrutinib
Ibrutinib, an irreversible oral inhibitor of Bruton's tyrosine kinase, has been used in the treatment of patients with multiple hematologic malignancies. A 59-year-old male with chronic lymphocytic leukemia was treated with 420 mg/day of ibrutinib. No evidence of bruising or diarrhea was noted....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868944/ https://www.ncbi.nlm.nih.gov/pubmed/27194982 http://dx.doi.org/10.1159/000445798 |